)
)
Cosmo Pharmaceuticals Investor Relations Material
Latest events
H2 2024
Cosmo Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Cosmo Pharmaceuticals N.V.
Access all reports
Established in 1997, Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, develops, manufactures, and distributes products for gastroenterology and endoscopy worldwide. The company offers drug delivery systems primarily rectal, topical, oral, nasal wafer based systems. Cosmo Pharmaceuticals aims to become a global leader in optimized therapies for selected gastroenterology and colorectal disease areas by leveraging its proprietary and differentiated technology.
Key slides for Cosmo Pharmaceuticals N.V.
H1 2024
Cosmo Pharmaceuticals N.V.
H2 2024
Cosmo Pharmaceuticals N.V.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
COPN
Country
🇨🇭 Switzerland